According to a new study that was published in the Drug Safety journal, statins could be one of the driving factors behind sporadic cases of ALS, which account for roughly nine out of ten ALS diagnoses. In the study, researchers looked at the reporting odds ratio, or ROR, of statins in relation to ALS and ALS-like symptoms. An ROR of 6 or greater generally suggests probable cause.
While the RORs for ALS were considered elevated for all of the statins studied, they discovered that lipophilic statins like Lovastatin (Altoprev) had an alarmingly high ROR of 107. Meanwhile, the ROR for Simvastatin (Zocor) was 23, while that of the popular statin Atorvastatin (Lipitor) was 17 and Rosuvastatin (Crestor) was 9.09. The researchers concluded that there is indeed a concerning connection that warrants further exploration.